

CLASSIFICATION: STEROIDAL AROMATASE INHIBITOR (AI)
ACTIVE SUBSTANCE: EXEMESTANE
FORM: 30 TABLETS x 25 MG
ACTIVE HALF-LIFE: ~24 HOURS
DOSAGE: MEN 25 MG ONCE DAILY
ACNE: POSSIBLE
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: RARE
AROMATIZATION: NONE
MANUFACTURER: PFIZER
Aromasin contains exemestane, a steroidal, irreversible aromatase inhibitor (AI) used under physician supervision for approved oncology indications. By permanently inactivating the aromatase enzyme (a "suicide inhibitor"), exemestane reduces the conversion of androgens to estrogens, thereby lowering circulating estradiol (E2). For bodybuilders, athletes, and fitness enthusiasts who work with licensed clinicians, understanding how an AI differs from selective estrogen receptor modulators (SERMs) is essential: AIs lower estrogen production, whereas SERMs modulate estrogen's effect at tissue receptors. Aromasin is a prescription medicine; use only as directed by your clinician and within your local laws.
Estrogen synthesis in peripheral tissues relies on aromatase, which converts androstenedione and testosterone into estrone and estradiol. Exemestane structurally resembles the aromatase substrate, binds at the catalytic site, and irreversibly deactivates the enzyme. This "steroidal" mechanism contrasts with non-steroidal AIs (e.g., anastrozole, letrozole), which bind reversibly. The practical implication is sustained enzyme inactivation until new aromatase is synthesized, often producing a robust reduction in E2 when dosed appropriately under medical guidance.
In sport and physique contexts, estradiol affects more than water balance—it supports mood, joint comfort, lipid metabolism, and bone health. For this reason, oversuppression of estrogen is counterproductive and risky. If your clinician determines an AI is indicated, the goal is physiologic balance, not zero estrogen. Expect lab-guided dosing, with periodic checks of E2 (and, where relevant, LH/FSH, SHBG, lipids, and bone markers) to ensure you stay in a healthy range while meeting performance goals founded on training, nutrition, and sleep.
Exemestane is well absorbed orally; taking it with food improves exposure. The terminal half-life is approximately 24 hours, enabling once-daily dosing in approved indications. Because exemestane irreversibly inactivates aromatase, clinical effects reflect both drug exposure and the time it takes for the body to synthesize new enzyme. Your prescriber may retest labs after several weeks on a stable dose to evaluate efficacy and tolerability before considering adjustments. Do not self-dose or "chase" same-day numbers—estradiol kinetics and tissue responses are slower than acute stimulant effects.
Your clinician selects based on laboratory data, symptoms, cardiovascular risk, bone health, and overall plan. Switching classes without supervision can worsen lipid profiles, joint comfort, or mood, and may decrease training adherence.
Commonly reported effects include joint ache or stiffness, fatigue, mild hot flashes, or headache. Because estradiol influences lipids and bone, clinicians may periodically evaluate lipid panels and, during long courses or higher risk scenarios, consider bone density monitoring. Rare hepatic events have been reported; baseline and periodic LFTs may be appropriate if clinically indicated. If you experience chest pain, shortness of breath, severe mood changes, unusual bleeding, or persistent musculoskeletal pain that limits training, seek medical advice promptly. Avoid stacking with unknown "estrogen blockers" or over-the-counter blends—many contain undisclosed actives and can complicate care.
For FDA-vetted details on indications, dosing, warnings, and interactions, consult an authoritative source such as MedlinePlus: Exemestane (Aromasin). Your clinician will tailor these principles to your goals and medical history.
Aromasin is not a shortcut to better training outcomes. Performance and physique changes come from progressive overload, adequate protein (commonly 1.6–2.2 g/kg/day), appropriate energy balance, sleep (7–9 h), and stress control. An AI—when indicated—addresses a specific physiological lever. Monitor joints and recovery: if aches rise or lifts stall despite sound programming, discuss labs and settings with your prescriber rather than self-adjusting.
Explore related prescription options often discussed—with clinicians—for estrogen management and recovery planning. These are not substitutes for medical care; use legally and with oversight:
This listing is for genuine Pfizer Aromasin 25 mg, 30 tablets. Store at room temperature away from moisture, heat, and light. Keep out of reach of children. Use only if prescribed and sourced legally in your jurisdiction. Discreet USA shipping; secure checkout.
Medical & legal disclaimer: Informational content only—not medical advice. Use prescription medicines strictly under a licensed clinician's supervision and in accordance with local laws.
Aromasin (exemestane) is a steroidal, irreversible AI that inactivates aromatase. Arimidex (anastrozole) and letrozole are non-steroidal, reversible AIs. Your clinician chooses based on labs, goals, and tolerability.
It can oversuppress E2 if used inappropriately. The objective is balance, not zero estrogen. Clinicians use labs and symptoms to guide dose and avoid joint pain, mood shifts, and lipid/bone issues.
Yes. Periodic E2 checks, and when appropriate lipid panels and bone health assessments, help confirm effectiveness and safety. Self-adjusting without labs is discouraged.
Only if your clinician advises it. AI + SERM has specific, lab-guided use cases. Unsupervised combinations can cause hormone imbalance and adverse effects.
Joint ache, fatigue, hot flashes, or headache are common. Report persistent musculoskeletal pain, mood changes, unusual bleeding, or signs of liver issues to your clinician promptly.
Please log in to write AROMASIN review.
CLASS: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: EXEMESTANE
FORM: 100 PILLS x 25 MG
ACTIVE HALF-LIFE: 9 HOURS
DOSAGE: MEN 12.5-25 MG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
CLASS: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: EXEMESTANE
FORM: 30 PILLS x 25 MG
ACTIVE HALF-LIFE: 24 HOURS
DOSAGE: 25 MG/DAY WITH MEALS
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: BLOCKED
MANUFACTURER: KALPA PHARMACEUTICALS
CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: EXEMESTANE
FORM: 50 TABLETS x 25 MG
ACTIVE HALF-LIFE: ~24 HOURS
DOSAGE: 12.5–25 MG/DAY OR EOD
ACNE: REDUCED
WATER RETENTION: SIGNIFICANTLY REDUCED
HIGH BLOOD PRESSURE (HBP): REDUCED RISK
HEPATOTOXICITY: NO
AROMATIZATION: PERMANENTLY BLOCKED
MANUFACTURER: AXIOLABS
CLASSIFICATION: AROMATASE INHIBITOR (AI)
ACTIVE SUBSTANCE: EXEMESTANE
FORM: 50 TABLETS × 25 MG
ACTIVE HALF-LIFE: 24–30 HOURS
DOSAGE: MEN 12.5–25 MG/DAY OR EOD
ACNE: REDUCED
WATER RETENTION: MINIMAL
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: LOW
AROMATIZATION: BLOCKED
MANUFACTURER: BRITISH DRAGON PHARMACEUTICALS